Protalix BioTherapeutics Inc. (PLX) is priced at $1.71 after the most recent trading session. At the very opening of the session, the stock price was $1.56 and reached a high price of $1.74, prior to closing the session it reached the value of $1.72. The stock touched a low price of $1.56.
Recently in News on June 28, 2021, Protalix BioTherapeutics to Participate in a Fireside Chat on June 30, 2021. Zacks Investment Research to host webcast and conference call at 9:00 a.m. EDT. You can read further details here
Protalix BioTherapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.0200 on 02/10/21, with the lowest value was $1.4601 for the same time period, recorded on 07/19/21.
Protalix BioTherapeutics Inc. (PLX) full year performance was -53.26%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Protalix BioTherapeutics Inc. shares are logging -75.64% during the 52-week period from high price, and 17.12% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.46 and $7.02.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 774230 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Protalix BioTherapeutics Inc. (PLX) recorded performance in the market was -52.62%, having the revenues showcasing -70.34% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 78.06M, as it employees total of 207 workers.
Protalix BioTherapeutics Inc. (PLX) in the eye of market guru’s
During the last month, 0 analysts gave the Protalix BioTherapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.4681, with a change in the price was noted -3.16. In a similar fashion, Protalix BioTherapeutics Inc. posted a movement of -64.78% for the period of last 100 days, recording 1,709,029 in trading volumes.
Protalix BioTherapeutics Inc. (PLX): Stocks Technical analysis and Trends
Raw Stochastic average of Protalix BioTherapeutics Inc. in the period of last 50 days is set at 15.64%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 42.14%. In the last 20 days, the company’s Stochastic %K was 35.53% and its Stochastic %D was recorded 23.66%.
If we look into the earlier routines of Protalix BioTherapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -52.62%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -61.86%, alongside a downfall of -53.26% for the period of the last 12 months. The shares increased approximately by 6.17% in the 7-day charts and went up by -10.88% in the period of the last 30 days. Common stock shares were lifted by -70.34% during last recorded quarter.